The inhibitory activity of SCH 39304 and its enantiomers on radial growth and on the target enzyme, sterol 14 -demethylase, in Aspergillus fumigatus was studied to assess the role of stereochemistry in the efficacy of the drug. SCH 39304 and the RR (+) enantiomer were active in inhibiting the growth while no inhibition in the growth was observed with the SS (-) enantiomer. The MIC of SCH 39304 for the growth was about twice that of the RR (+) enantiomer. The differences in IC 50 s of SCH 39304 and its enantiomers for cell-free ergosterol biosynthesis correlated with their variations in MICs and type II binding spectra indicated the SS (-) enantiomer failed to bind to microsomal P450. These results show that the difference between SS (-) and RR (+) enantiomers in interacting with the target enzyme is the cause for significant difference in the potency between these two forms.
Introduction
A large number of azole antifungal agents have been developed and used with considerable success in treating mycotic infections in plants as well as in animals. 1, 2 Studies on mode of action revealed that these drugs act mainly by interfering with the cytochrome P450-dependent enzyme sterol 14 -demethylase, which is responsible for C14 demethylation of sterols in ergosterol biosynthesis. The consequences of this inhibition are depletion of ergosterol and accumulation of 14 -methyl sterols, which cause alterations in membrane fluidity, permeability, activities of membrane-bound enzymes, such as those for nutrient transport and chitin synthesis, and ultimately growth arrest. 3 The overall effect of azole drugs is fungistatic, but at higher concentrations they may be fungicidal in some fungal species. 4 Aspergillus fumigatus, which causes invasive aspergillosis, has emerged recently as an important pathogen in immunosuppressed individuals and is a leading cause of mortality in bone-marrow transplant recipients. 5, 6 The potencies of different azole drugs varied between 10-and 1000-fold when tested in in-vitro growth inhibition of A.
fumigatus. This variation is probably due to differences in either permeability or affinity to the target enzyme (unpublished observation). Azole drug inhibition of sterol 14 -demethylase occurs through the interaction of the nucleophilic N of the ring (N 3 of imidazole or N 4 of triazole) of the drug to the sixth co-ordination position of the ferric haem of cytochrome P450. 7 However, the selectivity and affinity of an azole drug for fungal cytochrome P450 is determined by the interaction of the N1 substituent group to the substrate binding region in the apoprotein. This view was mainly based on carbon monoxide displacement studies which showed that exchange of N-heterocycles of ketoconazole or itraconazole did not alter the affinity of the drug to microsomal P450 of Candida albicans but deacylation of the N1 substituent group of ketoconazole did affect the affinity. 8, 9 In addition the affinity and selectivity of azoles for P450s is also influenced by stereoisomerism of the N1 substituents. 10 However, comparatively little is known about stereoselective interaction of azoles with the target enzyme.
11 SCH 39304 (racemic mixture) contains RR (+) (SCH 42427) and SS (-) (SCH 42426) enantiomers (Figure 1 ) in equal proportion and is a triazole compound that has been developed for oral administration and topical treatment, but was not commercialized. 12 Preliminary studies showed that the R R (+) enantiomer was the active form, not the S S (-) enant i o m e r 1 3 and recently studies on binding of the transactive form to heterologous expressed sterol 14 -demethylase of C. albicans have been reported. 1 4 In the present study we have investigated the stereoselective interaction of SCH 39304 and its enantiomers with sterol 14 -demethylase of A. fumigatus in order to correlate with their antifungal a c t i v i t y .
Materials and methods

Organisms and chemicals
A. fumigatus H06-03 (Pfizer Central Research Culture Collection, Sandwich, UK) was used in this study. Unless otherwise stated all chemicals were purchased from Sigma (Poole, UK). SCH 39304 and its enantiomers were kindly provided by Schering-Plough Research (Bloomfield, NJ, USA).
In-vitro susceptibility tests
The potencies of SCH 39304 and its enantiomers on A. fumigatus H06-03 mycelial growth were assessed by measuring the radial growth on Sabouraud agar containing various concentrations of drug after transferring a thin mat of mycelium of uniform size (0.4 cm in diameter) on to the agar medium and incubating for 48 h at 37°C. 15 
Sterol isolation and gas chromatography/mass spectrometry analysis
The sterols were extracted as nonsaponifiable lipids from the cultures grown for 24 h at 37°C and analysed by gas chromatography/mass spectrometry with comparison of fragment patterns in the literature.
16,17
Inhibition of cell-free ergosterol biosynthesis
Cell extracts were prepared from the 16 h old cultures lysed by mechanical disruption using glass beads in a Braun homogenizer. 18 Cell-free ergosterol biosynthesis was undertaken by following a method described by Ballard et al., 18 i.e. the cell extract was incubated with [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]mevalonate, NADPH and azole drug for 2 h at 37°C, then nonsaponifiable sterols were extracted from the reaction mixture, separated by thin-layer chromatography with a toluene and diethyl ether solvent mixture (9:1, v/v) and the radioactive sterols located by autoradiogram and identified by reference to standards.
Spectrophotometric analysis
Microsomal fraction was isolated with a specific content of 20 pmol of P450 per milligram of protein by a previously published method.
19 P450 content was estimated by using reduced carbon monoxide (CO) difference spectrum. 20 The type II binding spectra were recorded by adding each drug incrementally to 0.1 M microsomal P450. 19 The CO displacement of azole drug was carried out by measuring the reduced CO-difference spectrum for every 5 min after adding 5 M RR (+) enantiomer and incubating for 2 min on ice. 19 
Protein content estimation
Protein concentrations of cell-free extracts and microsomal fractions were estimated by bicinchoninic acid method using a kit provided by Sigma.
Results
Inhibition of radial growth
The growth of A. fumigatus was inhibited by SCH 39304 in a dose-dependent manner ( Figure 2 ) and complete inhibition was achieved at 10 M. When individual enantiomers were used for susceptibility studies dramatic differences in their potencies were observed; RR (+) was active in inhibiting the fungal growth while no inhibition in the growth was observed with SS (-) enantiomer. The concentration of RR (+) enantiomer required for complete inhibition of the growth was approximately half that for SCH 39304 inhibitory concentration (5 M). The concentration of SCH 39304 and its enantiomers required for inhibiting 50% of the growth is shown in the Table. Sterol analysis showed that ergosterol (>80% of the total sterols) is the major sterol in untreated cultures and it was reduced to below 20% of the total sterols after treating with the MIC of the RR (+) enantiomer. A decrease in ergosterol levels and a concomitant increase in C14 -methyl sterols levels (data not shown) in treated cultures were indicative of sterol 14 -demethylase inhibition.
In-vitro ergosterol biosynthesis inhibition
Cell-free ergosterol biosynthesis was carried out to study the sterol 14 -demethylase activity and its inhibition by SCH 39304 and its enantiomers. The biosynthesis of ergosterol was estimated by measuring the incorporation of [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]mevalonate into it. The ergosterol biosynthesis was inhibited by SCH 39304 and the RR (+) enantiomer in a dose-dependent manner (Figure 3 ) but to different degrees and the decrease in ergosterol synthesis correlated with the accumulation of eburicol (data not shown), the sterol 14 -methyl demethylase substrate. However, no inhibition in the biosynthesis was observed with the SS (-) enantiomer. The half inhibitory concentration (IC 50 ) of SCH 39304 was approximately twice that of the RR (+) enantiomer for cell-free ergosterol biosynthesis (Table I ). The differences observed in IC 50 s of SCH 39304 and its enantiomers for sterol 14 -demethylase in cell-free extracts are in agreement with the differences obtained in MICs for the growth.
Spectrophotometric interaction studies
The investigation was extended further by studying the interaction of SCH 39304 and its isomers with microsomal cytochrome P450 of A. fumigatus. SCH 39304 and RR (+) enantiomer produced a typical type II spectrum indicative of a low spin state haem iron in the P450 resulting from the binding of azole to haem as a sixth ligand. 21 This spectrum was characterized by an absorbance maximum at Table. The RR (+) enantiomer's inhibitory effect on CO-P450 complex formation was studied to determine the relative affinity of microsomal P450 for the drug. The drug displacement by CO increased gradually with time and reached maximum at 30 min when only 20% of the P450 was azole-bound.
Discussion
Studies on the inhibition of cell growth, in-vivo and invitro ergosterol biosynthesis by SCH 39304 and its enantiomers, and their interaction with microsomal P450 show an extreme variation in the activity between RR (+) and SS (-) enantiomers. The potency of SCH 39304 is approximately half that of the RR (+) enantiomer and the results explain this, indicating that the SS (-) enantiomer is inactive due to its inability to interact with the target enzyme. However, its presence in the racemic mixture (SCH 39304) has not altered the activity of RR (+) enantiomer. In type II binding studies the spectral response with the active form was saturated at a 1:10 molar ratio of the microsomal P450 and the compound, respectively. This result confirms the observation of a previous study examining the interactions of A. fumigatus microsomal P450 with itraconazole and fluconazole. 19 It is known that azole drugs bind with sterol 14 -demethylase of C. albicans 22 and Saccharomyces cerevisiae 23 in 1:1 stoichiometry. However, in this and another study, 19 stoichiometric interaction was not observed. This might be explained by the presence of a variety of P450 isozymes in the microsomal fraction of A. fumigatus which could differ in the affinity for azoles. This view is supported by others 24, 25 who demonstrated that A. fumigatus microsomal P450 expressed constitutively was able to hydroxylate benzo(a)pyrene at the 3 position and progesterone at the 11 position.
Recent reports on stereoselective interaction of azole drugs with S. cerevisiae sterol 14 -demethylase suggested that the relative orientation of the hydrophilic group in the N1-substituent to the nucleophilic nitrogen of the ring is important to fit the azole drug in the active site of the target enzyme. 23, 26 In addition many studies carried out to evaluate the antifungal activity of enantiomers of several azole drugs indicated that the R-enantiomeric forms were more active than S-enantiomeric forms. 15, [27] [28] [29] The present study also revealed extreme variation between RR (+) and SS (-) enantiomers in their potencies. Molecular modelling predicted that the inability of SS (-) enantiomer to interact with C. albicans sterol 14 -demethylase is due to interference by the hydrophilic sulphonyl group of the N1-substituent with the interaction of the azole and the hydrophobic substrate binding pocket of the P450. 14 The data presented here could be useful in further understanding the active site of A. fumigatus, but the absence of binding by the SS (-) enantiomer appears to extend to all the P450 enzymes in the microsomal fraction of A. fumigatus which include a sterol 22 -desaturase, 30 ,31 a benzo(a)pyrene 3-hydroxylase 24 and a progesterone 11 -hydroxylase. 
